268 related articles for article (PubMed ID: 28390215)
21. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
22. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
23. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
24. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.
Buske C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020
[TBL] [Abstract][Full Text] [Related]
25. Skeletal clues apparently distinguishing Waldenstrom's macroglobulinemia from multiple myeloma and leukemia.
Rothschild BM; Ruhli F; Rothschild C
Am J Hum Biol; 2002; 14(4):532-7. PubMed ID: 12112574
[TBL] [Abstract][Full Text] [Related]
26. [Waldenstrom's macroglobulinemia with antibasement membrane activity of monoclonal immunoglobulin].
Pech JH; Moreau-Cabarrot A; Oksman F; Bedane C; Bernard P; Bazex J
Ann Dermatol Venereol; 1997; 124(4):325-8. PubMed ID: 9739939
[TBL] [Abstract][Full Text] [Related]
27. Distal Tibia and Foot Involvement in a Patient With Waldenstrom's Macroglobulinemia.
Priyanka P; Mercier R; Raiker R; Potugari B
WMJ; 2018 Jun; 117(2):88-91. PubMed ID: 30048579
[TBL] [Abstract][Full Text] [Related]
28. The Case ∣ Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia. Pseudohyperbicarbonatemia due to paraproteinemia.
Krish P; Jhaveri KD
Kidney Int; 2012 Mar; 81(6):603-5. PubMed ID: 22373713
[No Abstract] [Full Text] [Related]
29. [Waldenström's macroglobulinemia effectively treated with chronic daily oral administration of low-dose etoposide].
Itoh K; Shimada T; Horibe T; Kawai N; Sakata T; Fukuda M; Murohashi I; Bessho M; Takeuchi H; Hirashima K
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2131-4. PubMed ID: 9838919
[TBL] [Abstract][Full Text] [Related]
30. Rupture of an endometrioma with extremely high serum CA-125 level (> 10,000 IU/ml) and ascites resembling ovarian cancer.
Park CM; Kim SY
Eur J Gynaecol Oncol; 2014; 35(4):469-72. PubMed ID: 25118496
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M
Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811
[No Abstract] [Full Text] [Related]
32. Case report: bilateral simultaneous central retinal vein occlusion in Waldenström's macroglobulinemia.
Chanana B; Gupta N; Azad RV
Optometry; 2009 Jul; 80(7):350-3. PubMed ID: 19545847
[TBL] [Abstract][Full Text] [Related]
33. Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation.
Migkou M; Fotiou D; Gavriatopoulou M; Dimopoulos MA
Expert Opin Drug Saf; 2021 Sep; 20(9):987-995. PubMed ID: 34137347
[No Abstract] [Full Text] [Related]
34. Diffuse interstitial lung disease as a first manifestation of Waldenström's macroglobulinemia: case report and review of the literature.
Consuegra A; Marcos PJ; Vázquez R; Pombo J; Debén G; Verea-Hernando H
Arch Bronconeumol; 2014 Apr; 50(4):151-3. PubMed ID: 24629759
[TBL] [Abstract][Full Text] [Related]
35. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
[TBL] [Abstract][Full Text] [Related]
36. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.
Gertz MA
Am J Hematol; 2017 Feb; 92(2):209-217. PubMed ID: 28094456
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
Mailankody S; Landgren O
Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous Waldenström's macroglobulinemia: report of a case and overview of the spectrum of cutaneous disease.
Libow LF; Mawhinney JP; Bessinger GT
J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S202-6. PubMed ID: 11712059
[TBL] [Abstract][Full Text] [Related]
39. Membranoproliferative glomerulonephritis complicating Waldenström's macroglobulinemia.
Kratochvil D; Amann K; Bruck H; Büttner M
BMC Nephrol; 2012 Dec; 13():172. PubMed ID: 23259458
[TBL] [Abstract][Full Text] [Related]
40. [Waldenström's hyperglobulinemic purpura, Waldenström's macroglobulinemia].
Fischer M
Thromb Diath Haemorrh Suppl; 1968; 30():155-6. PubMed ID: 5005718
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
